FDA Inspection
Centaur Pharmaceuticals Private Ltd.Centaur Pharmaceuticals Private Ltd. – FDA Inspection, Jul 25, 2025
Record Details
This FDA Inspection record concerns Centaur Pharmaceuticals Private Ltd., with an inspection on July 25, 2025, issued by the Office of Inspections and Investigations, covering human drugs.
View Company Profile
ID · 9d1c7915-d7cc-4349-ae92-9a260f5df0f4
Inspection Facts
- Inspection number
- 1281041
- FDA center
- Human Drugs
Other FDA inspections of Centaur Pharmaceuticals Private Ltd.
5| Date | Classification | Office | Project area |
|---|---|---|---|
| November 21, 2022 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 27, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| October 13, 2016 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 5, 2015 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 11, 2011 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Centaur Pharmaceuticals Private Ltd.
- FDA Inspection 1192256 - 2022-11-21
- FDA Inspection 1107995 - 2019-09-27
- FDA Inspection 994501 - 2016-10-13
- FDA Inspection 914387 - 2015-02-05
- FDA Inspection 740701 - 2011-08-11
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.